These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15675609)

  • 1. PBT-1 Prana Biotechnology.
    Huckle R
    Curr Opin Investig Drugs; 2005 Jan; 6(1):99-107. PubMed ID: 15675609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clioquinol treatment in familiar early onset of Alzheimer's disease: a case report.
    Ibach B; Haen E; Marienhagen J; Hajak G
    Pharmacopsychiatry; 2005 Jul; 38(4):178-9. PubMed ID: 16025421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
    Crouch PJ; Barnham KJ; Bush AI; White AR
    Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NC-531 (Neurochem).
    Geerts H
    Curr Opin Investig Drugs; 2004 Jan; 5(1):95-100. PubMed ID: 14983981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease.
    Opazo C; Luza S; Villemagne VL; Volitakis I; Rowe C; Barnham KJ; Strozyk D; Masters CL; Cherny RA; Bush AI
    Aging Cell; 2006 Feb; 5(1):69-79. PubMed ID: 16441845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects?
    Carro E; Torres-Aleman I
    Expert Rev Neurother; 2004 Jan; 4(1):79-86. PubMed ID: 15853618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,1'-Xylyl bis-1,4,8,11-tetraaza cyclotetradecane: a new potential copper chelator agent for neuroprotection in Alzheimer's disease. Its comparative effects with clioquinol on rat brain copper distribution.
    Moret V; Laras Y; Pietrancosta N; Garino C; Quéléver G; Rolland A; Mallet B; Norreel JC; Kraus JL
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3298-301. PubMed ID: 16581247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effect of clioquinol for Alzheimer disease].
    Iwata N
    Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):223. PubMed ID: 18421848
    [No Abstract]   [Full Text] [Related]  

  • 9. Prana Biotechnology, Limited: metal attenuation in the treatment of neurodegenerative disease.
    McCarthy AM
    Chem Biol; 2004 Nov; 11(11):1473-4. PubMed ID: 15555993
    [No Abstract]   [Full Text] [Related]  

  • 10. Cystatin C: a potential target for Alzheimer's treatment.
    Levy E
    Expert Rev Neurother; 2008 May; 8(5):687-9. PubMed ID: 18457524
    [No Abstract]   [Full Text] [Related]  

  • 11. NS-2330 (Neurosearch).
    Thatte U
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1592-4. PubMed ID: 11763162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the mettle of PBT2 for Alzheimer's disease.
    Relkin NR
    Lancet Neurol; 2008 Sep; 7(9):762-3. PubMed ID: 18672401
    [No Abstract]   [Full Text] [Related]  

  • 13. 12th international conference on Alzheimer's disease. Part 2. 11-16 July 2009, Vienna, Austria.
    Filson S
    IDrugs; 2009 Sep; 12(9):537-8. PubMed ID: 19697268
    [No Abstract]   [Full Text] [Related]  

  • 14. The immune system, amyloid-beta peptide, and Alzheimer's disease.
    Weksler ME; Gouras G; Relkin NR; Szabo P
    Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
    Moreira PI; Smith MA; Zhu X; Santos MS; Oliveira CR; Perry G
    Expert Rev Neurother; 2004 Nov; 4(6):995-1004. PubMed ID: 15853526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease: Moving towards a vaccine.
    Holtzman DM
    Nature; 2008 Jul; 454(7203):418-20. PubMed ID: 18650906
    [No Abstract]   [Full Text] [Related]  

  • 17. Gamma-secretase: a complex target for Alzheimer's disease.
    Lundkvist J; Näslund J
    Curr Opin Pharmacol; 2007 Feb; 7(1):112-8. PubMed ID: 17169612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clioquinol treatment in familiar early onset of Alzheimer's disease: Ibach B et al., Pharmacopsychiatry 2005; 38: 178-179.
    Ritchie CW; Cappai R; Masters C
    Pharmacopsychiatry; 2006 Mar; 39(2):80. PubMed ID: 16555171
    [No Abstract]   [Full Text] [Related]  

  • 19. Insoluble problem?
    Nat Med; 2002 Mar; 8(3):191. PubMed ID: 11875465
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulating metals as a therapeutic strategy for Alzheimer's disease.
    Hung LW; Barnham KJ
    Future Med Chem; 2012 May; 4(8):955-69. PubMed ID: 22650238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.